Neuroscience
Crossover Study
100%
Blood Plasma
100%
Cannabidiol
100%
Endocannabinoid
100%
Tetrahydrocannabinol
100%
Meta-Analysis
100%
Randomized Controlled Trial
100%
Psychiatry
100%
Anandamide
85%
Cognitive Behavioral Therapy
75%
Cannabis
57%
Cannabinoid
57%
2-Arachidonoylglycerol
28%
Cannabinoid Receptor
28%
Electrical Brain Stimulation
25%
Omega 3 Fatty Acid
25%
Minocycline
25%
Risperidone
25%
Endocannabinoid System
14%
Oleoylethanolamide
14%
Serine
14%
Liquid Chromatography-Mass Spectrometry
14%
Nabiximols
14%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
100%
Cannabidiol
100%
Endocannabinoid
100%
Dronabinol
100%
Anandamide
85%
Cannabinoid
57%
Cannabis
57%
Tetrahydrocannabinol
42%
2-Arachidonoylglycerol
28%
Cannabinoid Receptor
28%
Serine
14%
Oleoylethanolamide
14%
Endocannabinoid System
14%
Nabiximols
14%
Medicine and Dentistry
Randomized Controlled Trial
100%
Preventive Psychiatry
100%
Meta-Analysis
100%
Cognitive Behavioral Therapy
75%
Odds Ratio
50%
Minocycline
25%
Clinical Population
25%
Targeted Therapy
25%
Risperidone
25%
Cognitive Remediation Therapy
25%
Systematic Review
25%
Electrical Brain Stimulation
25%
Omega-3 Fatty Acid
25%